VendiBean Co-Founder Reveals Key to Finding Work/Life Balance

 

Teal Cooper, co-founder of San Diego-based VendiBean LLC, joins hosts David and Matthew Shields of the “Like It’s Your Job” podcast from TSG Publishing to pull back the curtain on how her high-end espresso vending business is “disrupting” the coffee vending machine industry.

“My senior year, we saw a huge gap in the market for high-quality coffee that was conveniently located on-the-go, 24/7, on college campuses,” she says, recalling the early days of the venture.

With VendiBean’s five-year birthday right around the corner, the strategic consultants with the Shields Group interview Cooper about lessons learned and best practices from the enterprise she started with her own sibling, Tristan Cooper.

“The idea really came while I was studying abroad and saw the concept of a high-end espresso machine overseas,” Teal Cooper imparts to the podcast hosts. “My brother called me with the same idea, coincidentally — and we knew we had to do it.”

So, in early 2017, Teal Cooper and her brother set out with the simple objective of filling the dearth of high-quality coffee locations available around-the-clock on college campuses. But, as neither of the budding entrepreneurs had any background in making coffee or operating a business, they came across many unexpected hurdles on their path to success.

“We had to get our hands dirty,” she admits.

Five years later, VendiBean boasts 200 machines in three states and a staff of 10 employees.

As with many of their interview subjects, David and Matthew Shields touched on the successes, failures and lessons learned by a young business entrepreneur launching their own company. But with this episode in particular, the brothers engaged Teal Cooper in a lengthier exploration about how she found a work/life balance as her enterprise soared.

Listen to the full episode of “Like It’s Your Job” to hear how the highly motivated young professionals are finding ways to lower stress levels in their professional and personal lives — and how they can even carve out a “happy place” in the day-to-day work grind (literally, in Teal Cooper’s case).

For more information on the “Like It’s Your Job” podcast, check out the podcast’s page on Apple Podcasts. To explore Teal Cooper’s own podcast, “Real with Teal,” go to its website.

Follow us on social media for the latest updates in B2B!

Image

Latest

ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More
vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More